|
|
| Maladies Infectieuses > Etude de marché sectorielle |
|
|
|
|
€ 2 308,00 |
Editeur
: |
Global Industry Analyst |
Langue
: |
Anglais |
Date de publication : |
Octobre 2005 |
Taille du document : |
340 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Therapeutic Vaccines: More Trials and Tribulations
202 pages | Décembre 2005 |
IntroductionTherapeutic vaccines have faced numerous setbacks in recent years.
The only three vaccines to reach the market have had insignificant sales, while the pipeline has seen numerous high-pr |
6 460,00 €
|
| |
| |
Stakeholder Perspectives: Influenza Vaccines - Flying back Into Flu
166 pages | Décembre 2005 |
IntroductionInfluenza is a highly infectious disease which globally infects 10-20% of the population every year causing up to 500,000 deaths.
Although all persons are at risk, the elderly and the y |
6 460,00 €
|
| |
| |
Lower Detection Limits of HBV DNA Assays
1 pages | Janvier 2006 |
This Database Table is a one-page table of hard-to-find numerical information.
The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif |
80,00 €
|
| |
| |
The Antivirals Market Outlook: Market analysis of future growth and leading players by sector
178 pages | Janvier 2005 |
Business Insights have teamed up with IMS Health to bring you, ‘The Antivirals Market Outlook: Market analysis of future growth and leading players by sector.’ This unique product offering provides an |
2 443,75 €
|
| |
| |
Human Vaccines
481 pages | Octobre 2005 |
This report analyzes the worldwide markets for Human Vaccines in Millions of US$.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific (excluding Jap |
3 091,00 €
|
| |
| |
Pipeline Insight: Hepatitis C - Small Molecules, Big Revolution
237 pages | Avril 2005 |
IntroductionLess than 50% of chronically infected hepatitis C patients do not benefit from the current standard of care, pegylated interferon plus ribavirin.
In the short-term, the treatment landsc |
9 120,00 €
|
| |
| |
Monoclonal Antibody Therapies: Evolving into a $30 billion market
360 pages | Avril 2005 |
IntroductionThe monoclonal antibody market is one of the fastest growing and most lucrative sectors of the pharmaceutical industry, with exceptional 48.1% growth between 2003 and 2004.
It has the p |
12 160,00 €
|
| |
| |
Antiviral HIV Treatment in Developing Countries Number of Patients
1 pages | Janvier 2006 |
This Database Table is a one-page table of hard-to-find numerical information.
The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif |
80,00 €
|
| |
| |
Pipeline Insight: Hematological malignancies - Targeted treatments and immunotherapy infuse new blood
219 pages | Avril 2005 |
IntroductionGiven an enhanced understanding of the biological basis for oncogenesis and the benefit of immunotherapy approaches such as Genentech/Roche's Rituxan, it is no surprise that targeted treat |
9 120,00 €
|
| |
| |
Pipeline Insight: HIV - Hold Your Horses
216 pages | Avril 2005 |
IntroductionIn the current antiretroviral landscape, resistance in all three of the established classes is proving to be problematic.
Accordingly, current clinical trials are recruiting treatment-r |
9 120,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
|
|
This report analyzes the worldwide markets for HIV/AIDS Testing in Thousands of Units. The Product segments analyzed include HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin America. Annual forecasts are provided for each region and product segment for the period of 2000 through 2010. The report profiles 51 companies including many key and niche players worldwide such as Abbott Laboratories, Adaltis Inc., Bayer Diagnostics, bioMérieux, Bio-Rad Laboratories, Calypte Biomedical Corporation, Chiron Corp., Gen-Probe, Inc., Innogenetics NV, MedMira Laboratories, Inc., Medical Services International Inc., OraSure Technologies Inc., Ortho-Clinical Diagnostics and Roche Diagnostics Systems Inc.
|
|
|
PPLSEN
|
|
|
|
|
